Amedisys falls

Justice Department Sues to Block UnitedHealth’s $3.3 Billion Bid for Amedisys
Antitrust enforcers argue that the healthcare giant’s latest deal would illegally harm competition.
Amedisys falls as DOJ sues to block $3.3B sale to UnitedHealth (update)
Adds UnitedHealth comment.Amedisys (NASDAQ:AMED) dropped 1.8% as the Dept. of Justice confirmed it filed a lawsuit to challenge the home-health services provider's planned $3.3 billion sale to UnitedHealth (UNH).
U.S. sues to block UnitedHealth’s $3.3B purchase of Amedisys
The U.S. Department of Justice and three U.S. states filed a lawsuit on Tuesday to block UnitedHealth Group’s $3.3 billion acquisition of Amedisys Inc, citing concerns that the deal would reduce competition in the home health services market.
Justice Department sues to block $3.3 billion sale of Louisiana company
UnitedHealth Group planned to purchase Baton Rouge-based Amedisys. The antitrust complaint argues that combination would hinder access to home health and hospice services in the U.S.
Amedisys drops on report DOJ preparing lawsuit to block UnitedHealth deal
Amedisys (AMED) stock fell 2% in premarket trading as DOJ plans to challenge UnitedHealth's acquisition, sparking antitrust concerns.
Justice Department sues to block UnitedHealth Group’s $3.3 billion purchase of Amedisys
The government is citing concerns the deal would hinder access to home health and hospice services in the U.S.
US sues to block UnitedHealth's $3.3 billion purchase of Amedisys
The U.S. Department of Justice and three U.S. states filed a lawsuit on Tuesday to block UnitedHealth Group's $3.3 billion acquisition of Amedisys Inc, citing concerns that the deal would reduce competition in the home health services market.
Justice Department sues to block UnitedHealth’s $3.3 billion deal to acquire Amedisys
The complaint marks the second time since 2022 that DOJ has challenged deals in the Minnetonka-based company’s Optum division for health care services.
Amedisys falls as DOJ sues to block $3.3B sale to UnitedHealth
Amedisys (NASDAQ:AMED) dropped 1.5% as the Dept. of Justice confirmed a lawsuit to challenge the home-health services provider's planned $3.3 billion sale to UnitedHealth (UNH). The DOJ and three states filed a lawsuit on Tuesday to block the combination,
US sues to block UnitedHealth's $3.3 bln purchase of Amedisys
The Justice Department and three U.S. states filed a lawsuit on Tuesday to block UnitedHealth Group's $3.3 billion purchase of Amedisys Inc over concern the deal would harm competition in the market for home health services,
Yahoo9h
DOJ sues UnitedHealth amid $3.3 billion bid to buy home care giant Amedisys
A UnitedHealth spokesperson confirmed with WCCO that the suit involves the health insurance giant's proposed $3.3 billion ...
STAT11h
DOJ sues to block UnitedHealth takeover of home health giant Amedisys
The Department of Justice on Tuesday sued to prevent UnitedHealth Group from buying Amedisys, a deal the government said ...
Modern Healthcare21h
DOJ preps lawsuit to block UnitedHealth-Amedisys deal
The US Justice Department is moving to block UnitedHealth Group Inc.’s $3.3 billion purchase of Amedisys Inc. over concerns ...
AMED Q3 Earnings and Revenues Miss, Margins Dip, Stock Falls
Amedisys, for the third quarter of 2024, delivers year-over-year top-line growth across three of its segments - Home Health, ...
Amedisys Inc. Reports Steady Revenue Growth Amid Merger
Amedisys Inc ( (AMED) ) has released its Q3 earnings. Here is a breakdown of the information Amedisys Inc presented to its investors. Amedisys, ...
Nashville Post5d
Health Care Notes: Amedisys falls short in Q3 results
Home health company Amedisys, based in Louisiana and Nashville, fell short of estimates in its third quarter earnings report.
Amedisys Reports Third Quarter 2024 Financial Results
In light of the pending merger of the Company with UnitedHealth Group Incorporated, Amedisys will not conduct a quarterly earnings call to discuss the third quarter results. Non-GAAP Financial ...
Amedisys reports Q3 adjusted EPS $1.00, consensus $1.17
Reports Q3 revenue $587.7M, consensus $588.05M. Published first on TheFly – the ultimate source for real-time, market-moving breaking ...